We are international
• treatment options TEXT SIZE   
supportive care    back

ASCO 2010: Response of newly diagnosed myeloma with 1q21 amplification to bortezomib-based PAD induction therapy.
Douglas Joshua, MD
University of Sydney
Sydney, Australia

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles